Categories
Change Password!
Reset Password!
Doctors can suggest FDA-Approved wearable Ultrasound
device for treatment of soft tissue injuries and arthritis.
Being FDA- approved in 2013 after 7 long years of clinical research, the first-ever multi-hour wearable ultrasound device was developed by studying and improving the biophysical effects of ultrasound (US) therapy to quicken soft tissue repair.
The main idea behind this development was the application of the US for many hours, regularly, to enable soft tissue injuries healing utilized by a renowned, FDA cGMP and ISO 13585 medical technology company.
The Government agencies have invested a significant
amount of funding to further clinically confirm this device’s healing effects
on back pain, arthritis, and overuse injuries. From the year 2013 to 2020, the
wearable device went through extensive acceptance by athletes, plus
work-associated injury market areas. It has been sanctioned by several health
plans and insurance providers in the United States. As of 2020, this company
holds 46 patents worldwide and has offered healing benefits of US therapy to
more than 200,000 individuals. The researchers plan to provide the device’s
healing power to 100 million people throughout the world in the coming 5 years.
Zetroz
Dr. George Lewis' Lifelong Passion for Ultrasound Therapy Led Him to Develop sam®, the Only FDA-Approved Wearable Ultrasound Device That Heals Arthritis and Soft Tissue Damage
Comments (0)